Prostate cancer: Does genetic score justify early prostate biopsy?

摘要

A newly developed genetic risk score derived from studies of several single nucleotide polymorphisms has the potential to improve the prediction of prostate cancer detection on biopsy for men with PSA levels of 1-3ng/ml. Understanding the score's characteristic differences from biomarkers is important in order to utilize it correctly.